Summary
- Revenue
- CDXC current annual revenue is $99.60M, up +19.18% year-over-year
- Next Earnings
- As of today, the next earnings release for CDXC has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Niagen Bioscience, Inc. |
| Ticker | NASDAQ: CDXC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | chromadex.com |
| Employees | 104 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $99.60M | ||
| Revenue, 1Y Change | +19.18% | |
| $0.11 | ||
| EPS, 1Y Change | +257.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.11 | ||
| EPS Estimate | $0.12 | N/A |
| EPS Est. Change | +6.09% | N/A |
| $99.60M | ||
| Revenue Estimate | $118.50M | N/A |
| Revenue Est. Change | +18.98% | N/A |
| Current Price | - | |
| Price Target | $8.10 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.09 | -$0.07 | +22.22% | |
| $0.04 | $0.11 | +205.56% | |
| $0.12 | N/A | +6.09% | |
| $0.20 | N/A | +78.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $83.38M | $83.57M | +0.23% | |
| $96.94M | $99.60M | +2.75% | |
| $118.50M | N/A | +18.98% | |
| $143.83M | N/A | +44.41% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $99.60M | ||
| $0.11 | ||
| $61.59M | ||
| 61.84% | ||
| $7.73M | ||
| 7.76% | ||
| $8.55M | ||
| 8.58% | ||
| $9.21M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 3.57 | ||
| 3.06 | ||
| - | ||
| 7 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $46.09M | ||
| $44.51M | ||
| $68.28M | ||
| $64.10M | ||
| $22.18M | ||
| $17.95M | ||
| $2.65M | ||
| $994.00K | ||
| $8.53M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $91.87M | ||
| $53.86M | ||
| $38.01M | ||
| $47.84M | ||
| $1.48M | ||
| - | ||
| $305.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $12.11M | ||
| -$143.00K | ||
| $5.37M | ||
| $163.00K | ||
| $11.95M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Ladenburg Thalmann | → | |
| Roth MKM | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Roth MKM | → |
Analyst sentiment
Institutional ownership
Screeners with CDXC
FAQ
- What is the ticker symbol for Niagen Bioscience, Inc.?
- The ticker symbol for Niagen Bioscience, Inc. is NASDAQ:CDXC
- Does Niagen Bioscience, Inc. pay dividends?
- No, Niagen Bioscience, Inc. does not pay dividends
- What sector is Niagen Bioscience, Inc. in?
- Niagen Bioscience, Inc. is in the Healthcare sector
- What industry is Niagen Bioscience, Inc. in?
- Niagen Bioscience, Inc. is in the Biotechnology industry
- What country is Niagen Bioscience, Inc. based in?
- Niagen Bioscience, Inc. is headquartered in United States
- When did Niagen Bioscience, Inc. go public?
- Niagen Bioscience, Inc. initial public offering (IPO) was on June 25, 2008
- Is Niagen Bioscience, Inc. in the S&P 500?
- No, Niagen Bioscience, Inc. is not included in the S&P 500 index
- Is Niagen Bioscience, Inc. in the NASDAQ 100?
- No, Niagen Bioscience, Inc. is not included in the NASDAQ 100 index
- Is Niagen Bioscience, Inc. in the Dow Jones?
- No, Niagen Bioscience, Inc. is not included in the Dow Jones index
- When was Niagen Bioscience, Inc. last earnings report?
- Niagen Bioscience, Inc.'s most recent earnings report was on May 8, 2025
- When does Niagen Bioscience, Inc. report earnings?
- The date for Niagen Bioscience, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CDXC Official Website www.chromadex.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1386570/000162828025023127/0001628280-25-023127-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1386570/000162828025009774/0001628280-25-009774-index.htm
- CDXC Profile on Yahoo Finance finance.yahoo.com/quote/CDXC
- CDXC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cdxc
